PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

50 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
NCD Risk Factors Collaboration (Döring, A. ; Gieger, C. ; Heier, M. ; Meisinger, C. ; Peters, A. ; Stieber, J. ; Stöckl, D. ; Thorand, B.): Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398, 957-980 (2021)
2.
Neumann, A.U. ; Goekkaya, M.* ; Dorgham, K.* ; Traidl-Hoffmann, C. & Gorochov, G.*: Tocilizumab in COVID-19 therapy: Who benefits, and how? Lancet 398, 299-300 (2021)
4.
GBD 2019 Risk Factors Collaborators (Breitner, S.): Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1223-1249 (2020)
5.
NCD Risk Factors Collaboration (Meisinger, C. ; Müller-Nurasyid, M. ; Peters, A.): Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: A pooled analysis of 2181 population-based studies with 65 million participants. Lancet 396, 1511-1524 (2020)
6.
von Mutius, E. & Smits, H.H.*: Primary prevention of asthma: From risk and protective factors to targeted strategies for prevention. Lancet 396, 854-866 (2020)
7.
Brunner, F.J.* et al.: Application of non-HDL cholesterol for population-based cardiovascular risk stratification: Results from the Multinational Cardiovascular Risk Consortium. Lancet 394, 2173-2183 (2019)
8.
Matthews, D.R.* et al.: Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): A 5-year, multicentre, randomised, double-blind trial. Lancet 394, 1519-1529 (2019)
9.
Lorkowski, S.* ; Richter, M.* ; Linseisen, J. & Watzl, B.*: Associations of fats and carbohydrates with cardiovascular disease and mortality—PURE and simple? Lancet 391, 1678-1679 (2018)
10.
Stumvoll, M.* & Tschöp, M.H.: Twice the benefits with twincretins? Lancet 392, 2142-2144 (2018)
11.
Wood, A.M.* et al.: Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 391, 1513-1523 (2018)
12.
EUMODIC Consortium (Döring, A. ; Meisinger, C. ; Müller-Nurasyid, M. ; Peters, A. ; Stieber, J. ; Stöckl, D.): Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet 389, 37-55 (2017)
13.
Ezzati, M.* et al.: Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627-2642 (2017)
14.
NCD Risk Factors Collaboration et al.: Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387, 1377-1396 (2016)
15.
NCD Risk Factors Collaboration (Müller-Nurasyid, M. ; Peters, A. ; Stöckl, D. ; Ezzati, M.*): Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513-1530 (2016)
16.
Miras, A.* et al.: Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone. Lancet 385, 392 (2015)
17.
Swerdlow, D.I.* et al.: HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials. Lancet 385, 351-361 (2015)
18.
Dick, K.J.* et al.: DNA methylation and body-mass index: A genome-wide analysis. Lancet 383, 1990-1998 (2014)
19.
Wormser, D.* et al.: Metabolic mediators of body-mass index and cardiovascular risk. Lancet 383, 2042-2043 (2014)
20.
Beelen, R.* et al.: Effects of long-term exposure to air pollution on natural-cause mortality: An analysis of 22 European cohorts within the multicentre ESCAPE project. Lancet 383, 785-795 (2013)